Clinical Research Directory
Browse clinical research sites, groups, and studies.
Prognosis of METTL-14 in Endometrial Carcinoma
Sponsor: Assiut University
Summary
1. To evaluate immunohistochemical expression of METTL14 in type1 endometrial carcinoma. 2. To evaluate the correlation between METTL14 expression and clinicopathological parameters of patients with type 1endometrial carcinoma such as tumor grade, lymhovascular invasion, age of pateints, tumor stage, presence of myometrial invasion and presence of cervical stroma affection. 3. To assess correlation of METTL-14 expression with disease free survival and overall survival.
Official title: Prognostic Impact of Immunohistochemical Expression of METTL-14 in Endometrial Carcinoma
Key Details
Gender
FEMALE
Age Range
Any - Any
Study Type
OBSERVATIONAL
Enrollment
50
Start Date
2025-09-27
Completion Date
2026-10
Last Updated
2025-09-30
Healthy Volunteers
Not specified
Interventions
Observation
observation of METTL-14 prognosis
IHC
IHC of METTL-14
Locations (1)
AssuitU
Asyut, Egypt